Drug Profile
Spiroglumide
Alternative Names: CR 2093; CR 2158; CR 2194Latest Information Update: 23 Aug 2002
Price :
$50
*
At a glance
- Originator Rottapharm
- Class Antineoplastics; Antiulcers
- Mechanism of Action Cholecystokinin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Peptic ulcer